Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Cannon

Showing results (191-200 of 858) with videos related to

Pageof 86
Sort By:
Journal of the American College of Cardiology|April 11, 2009
Interaction between cigarette smoking and clinical benefit of clopidogrelNihar R Desai, Jessica L Mega, Songtao Jiang, et al.
The American Journal of Cardiology|August 10, 2010
On-statin cholesteryl ester transfer protein mass and risk of recurrent coronary events (from the pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 [PROVE IT-TIMI 22] study)Amit V Khera, Megan L Wolfe, Christopher P Cannon, et al.
Journal of Thrombosis and Thrombolysis|February 15, 2011
Impact of reduced glomerular filtration rate on outcomes in patients with ST-segment elevation myocardial infarction undergoing fibrinolysis: a CLARITY-TIMI 28 analysisShaheeda Ahmed, C Michael Gibson, Christopher P Cannon, et al.
Circulation. Cardiovascular Quality and Outcomes|April 14, 2011
Benefit of intensive statin therapy in women: results from PROVE IT-TIMI 22Quynh A Truong, Sabina A Murphy, Carolyn H McCabe, et al.
The American Journal of Cardiology|December 14, 2004
Safety of stress testing during the evolution of unstable angina pectoris or non-ST-elevation myocardial infarctionJuhana Karha, C Michael Gibson, Sabina A Murphy, et al.
The American Journal of Cardiology|August 30, 2008
Is coding for myocardial infarction more accurate now that coding descriptions have been clarified to distinguish ST-elevation myocardial infarction from non-ST elevation myocardial infarction?Benjamin A Steinberg, William J French, Eric Peterson, et al.
Journal of the American College of Cardiology|August 26, 2017
Reply: Ezetimibe, Risk Stratification, and Secondary PreventionErin A Bohula, David A Morrow, Robert P Giugliano, et al.
Journal of Shoulder and Elbow Surgery|February 3, 2009
Functional outcome following endoprosthetic reconstruction of the proximal humerusChristopher P Cannon, Giovanni U Paraliticci, Patrick P Lin, et al.
Orthopedics|March 19, 2009
Proximal femoral endoprosthesis for the treatment of metastaticChristopher P Cannon, Attiqa N Mirza, Patrick P Lin, et al.
Archives of Drug Information|February 17, 2010
A Comparison of Cardiovascular Biomarkers in Patients Treated for Three Months with Etoricoxib, Celecoxib, Ibuprofen, and PlaceboChristopher P Cannon, Cong Chen, Sean P Curtis, et al.
Pageof 86

Showing results (191-200 of 858) with videos related to

Sort By:
Pageof 86
Journal of the American College of Cardiology|April 11, 2009
Interaction between cigarette smoking and clinical benefit of clopidogrelNihar R Desai, Jessica L Mega, Songtao Jiang, et al.
The American Journal of Cardiology|August 10, 2010
On-statin cholesteryl ester transfer protein mass and risk of recurrent coronary events (from the pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 [PROVE IT-TIMI 22] study)Amit V Khera, Megan L Wolfe, Christopher P Cannon, et al.
Journal of Thrombosis and Thrombolysis|February 15, 2011
Impact of reduced glomerular filtration rate on outcomes in patients with ST-segment elevation myocardial infarction undergoing fibrinolysis: a CLARITY-TIMI 28 analysisShaheeda Ahmed, C Michael Gibson, Christopher P Cannon, et al.
Circulation. Cardiovascular Quality and Outcomes|April 14, 2011
Benefit of intensive statin therapy in women: results from PROVE IT-TIMI 22Quynh A Truong, Sabina A Murphy, Carolyn H McCabe, et al.
The American Journal of Cardiology|December 14, 2004
Safety of stress testing during the evolution of unstable angina pectoris or non-ST-elevation myocardial infarctionJuhana Karha, C Michael Gibson, Sabina A Murphy, et al.
The American Journal of Cardiology|August 30, 2008
Is coding for myocardial infarction more accurate now that coding descriptions have been clarified to distinguish ST-elevation myocardial infarction from non-ST elevation myocardial infarction?Benjamin A Steinberg, William J French, Eric Peterson, et al.
Journal of the American College of Cardiology|August 26, 2017
Reply: Ezetimibe, Risk Stratification, and Secondary PreventionErin A Bohula, David A Morrow, Robert P Giugliano, et al.
Journal of Shoulder and Elbow Surgery|February 3, 2009
Functional outcome following endoprosthetic reconstruction of the proximal humerusChristopher P Cannon, Giovanni U Paraliticci, Patrick P Lin, et al.
Orthopedics|March 19, 2009
Proximal femoral endoprosthesis for the treatment of metastaticChristopher P Cannon, Attiqa N Mirza, Patrick P Lin, et al.
Archives of Drug Information|February 17, 2010
A Comparison of Cardiovascular Biomarkers in Patients Treated for Three Months with Etoricoxib, Celecoxib, Ibuprofen, and PlaceboChristopher P Cannon, Cong Chen, Sean P Curtis, et al.
Pageof 86